TG Therapeutics | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Alaunos Therapeutics USD 2K 0 2024-12
Amgen USD 33.58B 45M 2025-03
Ardelyx USD 24K 0 2024-12
Arrowhead Research USD 218K 1000 2024-12
Bayer EUR 2.52B 0 2024-12
Biogen USD 100K 0 2025-03
Corcept Therapeutics USD 136K 1000 2024-12
Dynavax Technologies USD 125K 6K 2024-12
Gilead Sciences USD 1000K 0 2024-12
J&J USD 3.12B 0 2024-12
Novartis USD 793M 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
TG Therapeutics USD 156K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



TG Therapeutics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.